Urosphere/ Urolead and Institut Curie will present their last results at the AACR meeting, Denver: Bladder Cancer: Transforming the Field.


aacr image

Urosphere/ Urolead and Institut Curie will present their last results at the AACR meeting, Denver: Bladder Cancer: Transforming the Field.

Fruit of a long term collaboration, Urosphere and its affiliate Urolead (Toulouse) and Institut Curie (Paris) will present a fully characterized biobank of PDXs from bladder cancers and its relevant use as a drug discovery platform.

The results will be presented in poster session A, on Sunday, May 19th and in plenary session 5, on Monday, May 20th.

Title: Establishment of a panel of patient-derived tumor xenograft models recapitulating molecular heterogeneity and drug response of muscle-invasive bladder tumors.

Isabelle Bernard-Pierrot, Institut Curie, Paris, France, poster board number A24

Title: PDX and genetic mouse models for deciphering signaling pathways in bladder cancer.
François R. Radvanyi, Institut Curie, Paris, France, Plenary Session 5: Models for Discovery

logos aacr denver

Please, do not hesitate to attend these sessions and contact us.